16

General Information


DRACP ID  DRACP00163

Peptide Name   16

Sequence  YXG

Sequence Length  3

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HEp-2 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 4.6% inhibition at 10-6 M, 4.9% inhibition at 10-5 M, 12.6% inhibition at 10-4 M, 26.4% inhibition at 10-3 M MTT assay 72 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 11% inhibition at 10-6 M, 11.7% inhibition at 10-5 M, 11.6% inhibition at 10-4 M, 28.2% inhibition at 10-3 M MTT assay 72 h 1
HBL Melanoma Carcinoma 1.2% inhibition at 10-5 M, 3.3% inhibition at 10-4 M, 19.4% inhibition at 10-3 M MTT assay 72 h 1
HT-29 Colon adenocarcinoma Carcinoma 7.6% inhibition at 10-6 M, 3.8% inhibition at 10-5 M, 12.4% inhibition at 10-4 M, 22.4% inhibition at 10-3 M MTT assay 72 h 1
SW620 Colon adenocarcinoma Carcinoma 17% inhibition at 10-6 M, 13.5% inhibition at 10-5 M, 13.5% inhibition at 10-4 M, 25.3% inhibition at 10-3 M MTT assay 72 h 1
CaCo-2 Colon adenocarcinoma Carcinoma 8.1% inhibition at 10-6 M, 6.9% inhibition at 10-5 M, 8.1% inhibition at 10-4 M, 8.6% inhibition at 10-3 M MTT assay 72 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma 15.6% inhibition at 10-4 M MTT assay 72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  lead to apoptosis

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cα -dialkylated glycine (Aaa2,R )

Chiral  L



Physicochemical Information


Formula  C11H12N2O3

Absent amino acids  ACDEFHIKLMNPQRSTVW

Common amino acids  GYX

Mass  36608

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  80

Hydrophobicity  -56.67

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  745

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity

Doi 10.1021/jm051026

Year  +2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.